Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1

Journal of Infection

Volumn 35, Issue 1, 1997, Pages 41-46

  Gerard Y ^a,b   Hober, D ^a   Assicot, M ^c   Alfandari, S ^b   Ajana, F ^b   Bourez, J M ^b   Chidiac, C ^b   Mouton, Y ^b   Bohuon, C ^c   Wattre, P ^a  

^a CHU Rouen BG   (France)

^b Service Universitaire des Maladies Infectieuses et du Voyageur   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOCHEMICAL MARKER; CALCITONIN; HORMONE PRECURSOR;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CALCITONIN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PATIENT MONITORING; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SUPERINFECTION; TOXOPLASMOSIS; VIRUS INFECTION;

EID: 0030822181     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)90953-1     Document Type: Article

References (13)

1. Masur H. Management of opportunistic infections associated with HIV infection. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases 4th ed. New York: Churchill Livingstone. 1995; 1280-1294.
2. Assicot M, Gendrel D, Carsin H, Raymond J, Guilband J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis infection. Lancet 1993; 341: 515-518.
3. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992 41: 1-19.
4. Ghillani P, Motte P, Troalen F et al. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 1989; 49: 6845-6851.
5. Gérard Y, Hober D, Petijean S et al. High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 1995; 23: 310-311.
6. Davis TME, Assicot M, Bohuon C, St John A, Li GQ, Anh TK. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994; 88: 670-671.
7. Smith MD, Suputtamongkol Y, Chaowagul W et al. Elevated serum procalcitonin levels in patients with meliodosis. Clin Infect Dis 1995; 20: 641-645.
8. Benson CA, Ellner JJ. Mycobacterium avium Complex infection and AIDS: advances in theory and practice. Clin Infect Dis 1993; 17: 7-20.
9. Pitchenik AE, Fertel D. Mycobacterial disease in patients with HIV infection. In: Wormser GP, ed. AIDS and other manifestations of HIV infection. 2nd ed. New York: Raven Press. 1992: 297-313.
10. Simberkoff MS, Leaf HL. Bacterial infections in patients with HIV infection. In: Wormser GP, ed. AIDS and other manifestations of HIV infection. 2nd ed. New York: Raven Press. 1992: 269-275.
11. Krumholtz HM, Sande MA, Lo B. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med 1989; 86: 776-770.
12. Chidiac C, Alfandari S, Senneville E et al. Prospective study of bacterial infections in patients with HIV infection in the north France AIDS reference center (CISIH 18). In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, U.S.A. American Society for Microbiology 1995: 251.
13. Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-1608.